{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:13:35Z","timestamp":1792538015406,"version":"4.5.0"},"reference-count":85,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:p>Consensus has recently been reached by international pediatric subspecialty societies that otherwise unexplained persistent hyperandrogenic anovulation using age- and stage-appropriate standards are appropriate diagnostic criteria for polycystic ovary syndrome (PCOS) in adolescents. The purpose of this review is to summarize these recommendations and discuss their basis and implications. Anovulation is indicated by abnormal uterine bleeding, which exists when menstrual cycle length is outside the normal range or bleeding is excessive: cycles outside 19 to 90 days are always abnormal, and most are 21 to 45 days even during the first postmenarcheal year. Continued menstrual abnormality in a hyperandrogenic adolescent for 1 year prognosticates at least 50% risk of persistence. Hyperandrogenism is best indicated by persistent elevation of serum testosterone above adult norms as determined in a reliable reference laboratory. Because hyperandrogenemia documentation can be problematic, moderate-severe hirsutism constitutes clinical evidence of hyperandrogenism. Moderate-severe inflammatory acne vulgaris unresponsive to topical treatment is an indication to test for hyperandrogenemia. Treatment of PCOS is symptom-directed. Cyclic estrogen-progestin oral contraceptives are ordinarily the preferred first-line medical treatment because they reliably improve both the menstrual abnormality and hyperandrogenism. First-line treatment of the comorbidities of obesity and insulin resistance is lifestyle modification with calorie restriction and increased exercise. Metformin in conjunction with behavior modification is indicated for glucose intolerance. Although persistence of hyperandrogenic anovulation for \u22652 years ensures the distinction of PCOS from physiologic anovulation, early workup is advisable to make a provisional diagnosis so that combined oral contraceptive treatment, which will mask diagnosis by suppressing hyperandrogenemia, is not unnecessarily delayed.<\/jats:p>","DOI":"10.1542\/peds.2015-1430","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T01:47:46Z","timestamp":1448329666000},"page":"1154-1165","source":"Crossref","is-referenced-by-count":163,"title":["The Diagnosis of Polycystic Ovary Syndrome in Adolescents"],"prefix":"10.1542","volume":"136","author":[{"given":"Robert L.","family":"Rosenfield","sequence":"first","affiliation":[{"name":"Professor Emeritus of Pediatrics and Medicine, The University of Chicago Pritzker School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"2021120906160672500_B1"},{"issue":"3","key":"2021120906160672500_B2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage.","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021120906160672500_B3"},{"key":"2021120906160672500_B4"},{"issue":"6","key":"2021120906160672500_B5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study.","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2021120906160672500_B6","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2021120906160672500_B7","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021120906160672500_B8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.","volume":"84","author":"Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021120906160672500_B9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"issue":"18","key":"2021120906160672500_B10","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.","volume":"103","author":"Sam","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2021120906160672500_B11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1210\/jc.2005-1707","article-title":"Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.","volume":"91","author":"Leibel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021120906160672500_B12","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-2217","article-title":"Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.","volume":"90","author":"Sam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2021120906160672500_B13","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-1333","article-title":"High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.","volume":"94","author":"Coviello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2021120906160672500_B14","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"2021120906160672500_B15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries.","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2021120906160672500_B16","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"},{"key":"2021120906160672500_B17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"2021120906160672500_B18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"12","key":"2021120906160672500_B19","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2021120906160672500_B20"},{"key":"2021120906160672500_B21","first-page":"1","article-title":"The menstrual cycle.","volume":"7","author":"Vollman","year":"1977","journal-title":"Major Probl Obstet Gynecol"},{"issue":"5","key":"2021120906160672500_B22","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1542\/peds.2006-2481","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign.","volume":"118","author":"Diaz","year":"2006","journal-title":"Pediatrics"},{"issue":"9","key":"2021120906160672500_B23","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1210\/jc.2013-1770","article-title":"Clinical review: Adolescent anovulation: maturational mechanisms and implications.","volume":"98","author":"Rosenfield","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906160672500_B24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/joe.0.0970213","article-title":"Incidence of ovulation in the years after the menarche.","volume":"97","author":"Metcalf","year":"1983","journal-title":"J Endocrinol"},{"issue":"5","key":"2021120906160672500_B25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem-47-5-944","article-title":"Hormonal pattern of adolescent menstrual cycles.","volume":"47","author":"Apter","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021120906160672500_B26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9378(66)90398-X","article-title":"The prognosis for adolescents with menstrual abnormalities.","volume":"94","author":"Southam","year":"1966","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021120906160672500_B27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/jcem-65-3-488","article-title":"Circadian variations of luteinizing hormone can have two different profiles in adolescent anovulation.","volume":"65","author":"Porcu","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021120906160672500_B28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000180567","article-title":"Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology.","volume":"24","author":"Venturoli","year":"1986","journal-title":"Horm Res"},{"issue":"4","key":"2021120906160672500_B29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem.74.4.1548348","article-title":"Longitudinal evaluation of the different gonadotropin pulsatile patterns in anovulatory cycles of young girls.","volume":"74","author":"Venturoli","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021120906160672500_B30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence.","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"issue":"2","key":"2021120906160672500_B31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years.","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"issue":"11","key":"2021120906160672500_B32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/00016340802478166","article-title":"Prospective follow-up of menstrual disorders in adolescence and prognostic factors.","volume":"87","author":"Wiksten-Almstr\u00f6mer","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2021120906160672500_B33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/jc.2014-4290","article-title":"Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.","volume":"100","author":"Rosenfield","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021120906160672500_B34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development.","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"issue":"4","key":"2021120906160672500_B35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906160672500_B36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1987.01660260079018","article-title":"The relationship of mild hirsutism or acne in women to androgens.","volume":"123","author":"Reingold","year":"1987","journal-title":"Arch Dermatol"},{"key":"2021120906160672500_B37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021120906160672500_B38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1067\/mpd.2001.109790","article-title":"The prevalence of upper lip hair in black and white girls during puberty: a new standard.","volume":"138","author":"Lucky","year":"2001","journal-title":"J Pediatr"},{"issue":"1","key":"2021120906160672500_B39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12539043","article-title":"Plasma androgens in women with acne vulgaris.","volume":"81","author":"Lucky","year":"1983","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2021120906160672500_B40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky","year":"1997","journal-title":"J Pediatr"},{"key":"2021120906160672500_B41","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","article-title":"Evidence-based recommendations for the diagnosis and treatment of pediatric acne.","volume":"131","author":"Eichenfield","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"2021120906160672500_B42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cell.2006.01.026","article-title":"Sex steroids and the free hormone hypothesis.","volume":"124","author":"Rosner","year":"2006","journal-title":"Cell"},{"issue":"10","key":"2021120906160672500_B43","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement.","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906160672500_B44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"11","key":"2021120906160672500_B45","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021120906160672500_B46","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2021120906160672500_B47"},{"issue":"10","key":"2021120906160672500_B48","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021120906160672500_B49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions.","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2021120906160672500_B50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/jc.2012-1829","article-title":"Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.","volume":"98","author":"Bentzen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021120906160672500_B51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2021120906160672500_B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.08.002"},{"issue":"5","key":"2021120906160672500_B53","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021120906160672500_B54","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"issue":"9","key":"2021120906160672500_B55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"1","key":"2021120906160672500_B56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.","volume":"138","author":"Lewy","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"2021120906160672500_B57","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome.","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120906160672500_B58","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1210\/jc.2012-2697","article-title":"PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity.","volume":"98","author":"Huang","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021120906160672500_B59","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).","volume":"98","author":"Borruel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021120906160672500_B60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition.","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"9468","key":"2021120906160672500_B61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome.","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"2021120906160672500_B62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021120906160672500_B63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpeds.2011.04.027","article-title":"Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome.","volume":"159","author":"Nandalike","year":"2011","journal-title":"J Pediatr"},{"issue":"12","key":"2021120906160672500_B64","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021120906160672500_B65","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"3","key":"2021120906160672500_B66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"issue":"1","key":"2021120906160672500_B67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JPEM.2007.20.1.41","article-title":"Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome.","volume":"20","author":"Littlejohn","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021120906160672500_B68"},{"issue":"1","key":"2021120906160672500_B69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2362.2011.02550.x","article-title":"Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.","volume":"42","author":"Unluhizarci","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"2021120906160672500_B70"},{"key":"2021120906160672500_B71","doi-asserted-by":"crossref","unstructured":"Rosenfield RL. Polycystic ovary syndrome in adolescents. UpToDate. Available at: http:\/\/www.uptodate.com\/contents\/treatment-of-polycystic-ovary-syndrome-in-adolescents. Accessed July 2, 2015","DOI":"10.1542\/peds.2015-1430"},{"issue":"5","key":"2021120906160672500_B72","first-page":"363","article-title":"Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report.","volume":"32","author":"Rosenfield","year":"1987","journal-title":"J Reprod Med"},{"issue":"5","key":"2021120906160672500_B73","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.","volume":"94","author":"Bidet","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021120906160672500_B74","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/cen.12543","article-title":"The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.","volume":"82","author":"Livadas","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2021120906160672500_B75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120906160672500_B76","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","article-title":"The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.","volume":"94","author":"Pall","year":"2010","journal-title":"Fertil Steril"},{"key":"2021120906160672500_B77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","article-title":"Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.","volume":"1364","author":"Rosenfield","year":"2010","journal-title":"Brain Res"},{"key":"2021120906160672500_B78","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism.","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2021120906160672500_B79","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.2014-3196","article-title":"Approach to the patient: contraception in women with polycystic ovary syndrome.","volume":"100","author":"Yildiz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021120906160672500_B80","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"2021120906160672500_B81"},{"issue":"10","key":"2021120906160672500_B82","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2021120906160672500_B83","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021120906160672500_B84","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Human Reproduction Update"},{"issue":"8","key":"2021120906160672500_B85","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.","volume":"96","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/6\/1154\/1062276\/peds_2015-1430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/6\/1154\/1062276\/peds_2015-1430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:37:59Z","timestamp":1639096679000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/136\/6\/1154\/33905\/The-Diagnosis-of-Polycystic-Ovary-Syndrome-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":85,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,12,1]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-1430","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,1]]}}}